Dr Teresa Barata

Teresa Barata earned her PhD in Pharmaceutical Chemistry from the UCL School of Pharmacy. She then remained in the UK working with biotherapeutics, in the fields of characterisation, formulation, and product design and optimisation, across both academic and industrial environments. Teresa is co-author of 17 publications and co-inventor of one patent. She joined FairJourney Bio as Head of the Biophysical Characterisation Unit in 2020, was appointed Head of the Protein Science Division in 2021 and assumed the position of Chief Scientific Officer in 2023. Her most recent co-authored work, published in mAbs, reports a dual-specificity switch engineered to a pre-defined affinity window, holding two entirely unrelated targets in balance so that IL-12 activates only within the tumour microenvironment.